1. Short title This Act may be cited as the Clinical Laboratory Price Transparency Act of 2023 . 2. Promoting laboratory price transparency under the Medicare program Part E of title XVIII of the Social Security Act ( 42 U.S.C. 1395x et seq. ) is amended by adding at the end the following new section: 1899C. Laboratory price transparency requirement (a) In general Beginning January 1, 2025, each applicable laboratory that receives payment under this title for furnishing a specified clinical diagnostic laboratory test shall— (1) make publicly available (in a manner and form specified by the Secretary) on an Internet website the information described in subsection (b) with respect to each such specified clinical diagnostic laboratory test that such laboratory is so available to furnish; and (2) ensure that such information is updated not less frequently than annually. (b) Information described For purposes of subsection (a), the information described in this subsection is, with respect to an applicable laboratory and a specified clinical diagnostic laboratory test, the following: (1) The discounted cash price for such test (or, if no such price exists, the gross charge for such test). (2) If required by the Secretary, the deidentified minimum negotiated rate in effect between such laboratory and any group health plan or group or individual health insurance coverage for such test and the deidentified maximum negotiated rate in effect between such laboratory and any such plan or coverage for such test. (c) Method and format Not later than January 1, 2028, the Secretary shall establish one or more methods and formats for each provider of services and supplier to use in compiling and making public standard charges and prices (as applicable) pursuant to subsection (a). Any such method and format— (1) may be similar to any template made available by the Centers for Medicare & Medicaid Services as of the date of the enactment of this subsection